Systemic Sclerosis (SSc) is a rare and orphan disease (DPCM 12 gennaio 2017-GU SG n°65-S.O. n°15 - 18/03/2017) research hub

A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED, ADD-ON TRIAL EVALUATING EFFICACY AND SAFETY OF HYDROXYCHLOROQUINE IN EARLY SYSTEMIC SCLEROSIS (SSc)- HYDROXYSSc

This study is looking at whether adding hydroxychloroquine (Plaquenil) to usual treatment helps people with early systemic sclerosis. Researchers want to see if it improves symptoms and is safe, compared to a dummy pill, over 52 weeks.